Home Newsfeeds Novartis Earlier Launched New $11B Share Buyback Program

Novartis Earlier Launched New $11B Share Buyback Program

-Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-launches-new-share-buyback-up-10-its-stock-2023-03-13/

byCharles Gross

March 13, 2023

1 minute read

-Reuters

https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-launches-new-share-buyback-up-10-its-stock-2023-03-13/

TopBuild Announces Mutual Termination Of Agreement To Acquire Specialty Products And Insulation; TopBuild Paid A Termination Fee Of $23M

By Benzinga Newsdesk

April 22, 4:29 PM

TopBuild's Total Addressable Market is >$18 Billion;Significant Opportunity to Continue Driving Growth Organically and through AcquisitionsDAYTONA BEACH, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- TopBuild Corp.

BLD

News
Tech

Tesla Rival Rivian Opens ‘Space’ In Austin Merely 14 Miles Away From Giga Texas

By Anan Ashraf

June 14, 5:25 AM

Rivian opens new space in Tesla's home ground of Austin, Texas. It plans to compete with Tesla's EV lineup, offering SUVs and pickup trucks.

RIVN

Credit Suisse Maintains Neutral on Cogent Comms Hldgs, Raises Price Target to $57

By Benzinga Newsdesk

November 8, 8:33 AM

Credit Suisse analyst Sami Badri maintains Cogent Comms Hldgs (NASDAQ:CCOI) with a Neutral and raises the price target from $56 to $57.

CCOI

Amarin Announces VAZKEPA Receives Regulatory Approval In Switzerland

By Benzinga Newsdesk

December 7, 9:35 AM

-- Amarin Continuing Process for Obtaining National Pricing and Reimbursement in Switzerland in the Course of 2023 -- -- Swissmedic Approval Underpins Company's Presence and Expansion in Switzerland as its

AMRN

Novartis Earlier Launched New $11B Share Buyback Program

Related Posts

TopBuild Announces Mutual Termination Of Agreement To Acquire Specialty Products And Insulation; TopBuild Paid A Termination Fee Of $23M

Tesla Rival Rivian Opens ‘Space’ In Austin Merely 14 Miles Away From Giga Texas

Credit Suisse Maintains Neutral on Cogent Comms Hldgs, Raises Price Target to $57

Amarin Announces VAZKEPA Receives Regulatory Approval In Switzerland